According to our (Global Info Research) latest study, the global Recombinant Rat CDNF market size was valued at US$ 90.5 million in 2024 and is forecast to a readjusted size of USD 148 million by 2031 with a CAGR of 7.3% during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Cerebral dopamine neurotrophic factor (CDNF), also known as ARMET-like protein 1, is a protein encoded by the CDNF gene and it is widely expressed in neuronal and non-neuronal tissues. The cerebral dopamine neurotrophic factor (CDNF) also is a novel neurotrophic factor with strong trophic activity on dopaminergic neurons comparable to that of glial cell line-derived neurotrophic factor (GDNF). By research, CDNF prevents the 6-hydroxydopamine (6-OHDA)-induced degeneration of dopaminergic neurons and it might be beneficial for the treatment of parkinson's disease. The human CDNF cDNA encodes a 187 aa protein with a 24 aa signal sequence and a 163 mature sequence. Mature human CDNF shares 80%, 84%, 90% and 92% aa identity with mouse, rat, equine and bovine CDNF, respectively. Although CDNF mRNA and protein are expressed in pre- and post-natal mouse brain, they are most abundant in adult heart, skeletal muscle and testis. Transcripts within the postnatal mouse brain are concentrated in the hippocampus, thalamus, corpus callosum and optic nerve.
This report is a detailed and comprehensive analysis for global Recombinant Rat CDNF market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Recombinant Rat CDNF market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Recombinant Rat CDNF market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Recombinant Rat CDNF market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Recombinant Rat CDNF market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Recombinant Rat CDNF
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Recombinant Rat CDNF market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Bio-Techne, Scientists Helping Scientists, Abcam Limited, FUJIFILM Irvine Scientific, BD Biosciences, Bio-Rad Laboratories, Inc., BPS Bioscience, Inc., Elabscience, Yisheng Biotechnology (Shanghai) Co., Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Recombinant Rat CDNF market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Purity<95%
Purity ≥95%
Market segment by Application
University
Research Center
Major players covered
Thermo Fisher Scientific Inc.
Bio-Techne
Scientists Helping Scientists
Abcam Limited
FUJIFILM Irvine Scientific
BD Biosciences
Bio-Rad Laboratories, Inc.
BPS Bioscience, Inc.
Elabscience
Yisheng Biotechnology (Shanghai) Co., Ltd.
Abbkine
Beijing Biocreative Technology Co., Ltd.
Shanghai Yaji Biotechnology Co., Ltd.
Cellverse Co., Ltd.
Dalian Meilun Biotech Co., Ltd.
Sino Biological,Inc.
Prospec-Tany Technogene Ltd
ENZO
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Recombinant Rat CDNF product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Recombinant Rat CDNF, with price, sales quantity, revenue, and global market share of Recombinant Rat CDNF from 2020 to 2025.
Chapter 3, the Recombinant Rat CDNF competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Recombinant Rat CDNF breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Recombinant Rat CDNF market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Recombinant Rat CDNF.
Chapter 14 and 15, to describe Recombinant Rat CDNF sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Recombinant Rat CDNF. Industry analysis & Market Report on Recombinant Rat CDNF is a syndicated market report, published as Global Recombinant Rat CDNF Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Recombinant Rat CDNF market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.